IRON METABOLISM

PEDIATRICS ◽  
1956 ◽  
Vol 18 (2) ◽  
pp. 267-298
Author(s):  
Phillip Sturgeon

The infant has no route or organ for the physiologic excretion of iron. Clinically insignificant quantities are lost through the skin and gastrointestinal tract. Assimilation of iron by the adult does not exceed 10 per cent of that ingested in the food; natural foods have a relatively low content of iron. There is evidence from balance studies that at least some infants may have a greater capacity to absorb iron than adults; confirmatory studies using isotopic labeled iron in naturally occurring food, especially milk, would be most helpful in considering and re-evaluating this phase of iron nutrition in the infant. The intestinal mucosa tends to act as a barrier to the rapid entrance of iron into the circulation (mucosal block). Iron in serum is transported bound to a serum globulin (siderophilin); the latter is present in a two- to threefold excess of the concentration of iron in the serum (this represents the serum iron-binding capacity). Relative to adults, many normal infants have a reduced concentration of serum iron and increased iron-binding capacity. Similar changes are seen in iron deficiency states. Storage iron is found primarily in the liver and spleen in 2 chemical forms. One, ferritin, is detectable only by chemical means, and the other, hemosiderin, is visible microscopically and takes iron stains. The content of the latter in bone marrow is reduced in iron deficiency states. Also, hemosiderin is not found in the bone marrow of normal infants. The time required for the assimilation of iron, including metabolic transport across the intestinal mucosa, through the serum iron pool, into the bone marrow and out into the circulating erythrocytes, is very short; as little as 4 hours. The vast majority of iron metabolized internally comes from the daily breakdown of hemoglobin and, to a lesser extent, from other iron compounds such as myoglobin, cytochrome and ferritin. The dietary iron assimilated constitutes only a small percentage of the daily total iron turnover. Studies of iron turnover rates (ferro-kinetics) have not been performed in infants; the magnitude and significance of the additional factor created by rapid growth in such considerations is not known at present. The phyisologic anemia of late infancy is associated with evidence of depletion of iron in the various iron compartments: hemoglobin, serum iron, iron-binding capacity and iron stores. In view of recent data on the blood volume and concentration of hemoglobin of the newborn infant, considerable reduction in estimates of the total amount of iron present at birth are in order: A mean value of 200 mg. for a 3-kg. infant is consistent with these data, and is also consistent with studies of total iron content of stillborn fetuses over 3 kg. A relatively wide range in values, 120 to 320 mg. for total body iron are well within the limit's of normal. Calculations are presented to show that those infants endowed with the smaller quantities of iron at birth and a relatively rapid growth factor will have to assimilate iron at 3 times the rate of other normal infants. In the normal infant with reduced iron content at birth, the drain of iron from hemoglobin by growth of muscle and myoglobin mass may constitute a significant factor contributing to a profound degree of anemia. Preliminary studies on the prophylactic use of intramuscular iron indicate that many of the manifestations of iron deficiency in normal infancy can be altered. A statistically significant higher mean concentration of hemoglobin (0.7 gm./100 ml.) was achieved. Infants, so treated, with values for hemoglobin less than 11.0 gm./ 100 ml. were not observed, whereas 20 per cent of normal infants at 1 year of age had values for hemoglobin ranging from 9.4 to 11 gm./100 ml. Highly significant reductions in the total iron-binding capacity, serum copper and free erythrocyte protoporphyrin were achieved. Increases in the concentration of serum iron and mean erythrocyte hemoglobin concentration were also significant. The average mean corpuscular volume in the treated group was 78.9 µm.; this was not significantly different from the value of 77.2 in the control group. In previous studies using oral iron in large doses, the only one of the above manifestations of iron deficiency which was altered significantly was the concentration of hemoglobin. Except for staining of the skin, the intramuscular iron preparation employed gave no reactions. The iron requirement for the first year of life was given in 3 injections of 1 to 2 ml. without difficulty.

1981 ◽  
Vol 27 (2) ◽  
pp. 276-279 ◽  
Author(s):  
F Peter ◽  
S Wang

Abstract Ferritin values for 250 selected sera were compared with values for iron, total iron-binding capacity (TIBC), and transferrin saturation, to assess the potential of the ferritin assay for the detection of latent iron deficiency. The specimens were grouped (50 in each group) according to their values for iron and TIBC. In Group 1 (low iron, high TIBC) the saturation and ferritin values both indicated iron deficiency in all but one. In the 100 specimens of Groups 2 (normal iron, high TIBC) and 4 (normal iron, high normal TIBC), the saturation values revealed 16 iron-deficient cases, the ferritin test 55. For Groups 3 (low iron, normal TIBC) and 5 (low iron, low TIBC), the ferritin test revealed fewer cases of iron deficiency than did the saturation values (37 cases vs 51 cases, in the 100 specimens). Evidently the ferritin test detects iron deficiency in many cases for whom the serum iron and TIBC tests are not positively indicative. The correlation of serum ferritin with iron, TIBC, and transferrin saturation in the five groups was good only in the case of specimens for which the TIBC was normal; if it was abnormal the correlation was very poor.


2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Warqaa Khalaf ◽  
Haithem Ahmed Al-Rubaie ◽  
Sami Shihab

Anemia of chronic disease (ACD) and iron deficiency anemia (IDA) are the two most important types of anemia in rheumatoid arthritis (RA). Functional iron deficiency in ACD can be attributed to overexpression of the main iron regulatory hormone hepcidin leading to diversion of iron from the circulation into storage sites resulting in iron-restricted erythropoiesis. The aim is to investigate the role of circulating hepcidin and to uncover the frequency of IDA in RA. The study included 51 patients with RA. Complete blood counts, serum iron, total iron binding capacity, ferritin, and hepcidin- 25 were assessed. ACD was found in 37.3% of patients, IDA in 11.8%, and combined (ACD/IDA) in 17.6%. Serum hepcidin was higher in ACD than in control and the other groups (P≤0.001). It was strongly and positively correlated with ferritin (P<0.001), while hemoglobin, serum iron, and total iron binding capacity were negatively correlated with hepcidin (P=0.016, 0.022 and <0.001, respectively). High serum hepcidin was significantly associated with ACD in RA. IDA alone or combined with ACD was encountered in about a third of patients.


1966 ◽  
Vol 4 (3) ◽  
pp. 9-11

We have discussed iron preparations for adults in earlier articles;1 much of the information applies equally to children. Iron is not a ‘tonic’ and should be given only to prevent or correct iron deficiency. Estimation of the haemoglobin and inspection of a blood smear are the minimum investigations necessary before iron is prescribed in therapy. When deficiency is suspected in the absence of hypochromic anaemia, plasma iron and iron-binding capacity should be estimated and/or the bone marrow examined for haemosiderin crystals which disappear when iron stores are depleted.


1975 ◽  
Vol 21 (8) ◽  
pp. 1063-1066 ◽  
Author(s):  
Swei H Tsung ◽  
Waldemar A Rosenthal ◽  
Karen A Milewski

Abstract Because of uncertainty as to the molecular weight of transferrin, a previous comparison [Von der Heul et al., Clin. Chim. Acta 38, 347 (1972)] between transferrin content of serum and total iron-binding capacity cannot be definitive. We found a conversion factor for expressing transferrin as iron-binding capacity by measuring the maximum amount of iron bound by 1 mg of transferrin. We compared the resulting calculated value with values obtained by three other methods for measuring total iron-binding capacity. We agree with the previous observation that the latter, as measured radioisotopically, give higher results than would be judged from the transferrin content but the same as those for two chemical methods. The diffusion rate of transferrin in agar was the same irrespective of the degree of iron saturation. Serum transferrin concentrations were low in patients with anemia resulting from malignancy, chronic disorders, and cirrhosis of the liver, and high or normal in patients with iron deficiency anemia and in pregnant women or women who were taking birth-control pills. Measurement of transferrin concentration can be used to distinguish iron deficiency anemia from anemia resulting from chronic disorders, but offers no advantages over existing methods for estimating total ironbinding capacity.


Sign in / Sign up

Export Citation Format

Share Document